Literature DB >> 1601084

Subacute sclerosing panencephalitis (SSPE) in Papua New Guinea: a high incidence in young children.

K M Lucas1, R C Sanders, A Rongap, T Rongap, S Pinai, M P Alpers.   

Abstract

Eighty-seven cases of subacute sclerosing panencephalitis (SSPE) were diagnosed from September 1988 to April 1991 in Papua New Guinea (PNG), by demonstration of high-titre measles-specific antibodies in cerebrospinal fluid (CSF). For 1990 the annual incidence of SSPE, for the study provinces, was calculated to be 56 cases per million under 20 years of age and it is expected that this figure will be higher in 1991. The mean age of presentation was 4.9 years, with a male to female ratio of 1.8:1. An elevation in the ratio of immunoglobulin G as a percentage of total protein in CSF and an increase in the CSF:serum immunoglobulin G ratio was shown in SSPE patients. The dramatic appearance and high frequency of the disease in PNG might relate to the early age of measles infection encountered in children in this country.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601084      PMCID: PMC2272203          DOI: 10.1017/s0950268800050044

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  21 in total

1.  High incidence of subacute sclerosing panencephalitis (SSPE) in young children in Papua New Guinea.

Authors:  R C Sanders; M Brian; A Rongap; P D Watt; M P Alpers
Journal:  Med J Aust       Date:  1990 Dec 3-17       Impact factor: 7.738

2.  Subacute sclerosing panencephalitis: an epidemiologic study in Israel.

Authors:  D Soffer; L Rannon; M Alter; E Kahana; S Feldman
Journal:  Am J Epidemiol       Date:  1976-01       Impact factor: 4.897

3.  Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide.

Authors:  D M Musher; M J Luchi; D A Watson; R Hamilton; R E Baughn
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

4.  Epidemiology of subacute sclerosing panencephalitis (SSPE). A report of the SSPE registry.

Authors:  J T Jabbour; D A Duenas; J L Sever; H M Krebs; L Horta-Barbosa
Journal:  JAMA       Date:  1972-05-15       Impact factor: 56.272

5.  Production of antibody by the central nervous system in subacute sclerosing panencephalitis.

Authors:  R W Cutler; E Merler; J P Hammerstad
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

6.  Cerebrospinal fluid IgG, IgA, IgM, IgD, and IgE levels in central nervous system disorders.

Authors:  S T Nerenberg; R Prasad; M E Rothman
Journal:  Neurology       Date:  1978-10       Impact factor: 9.910

7.  Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).

Authors:  N Zilber; L Rannon; M Alter; E Kahana
Journal:  Neurology       Date:  1983-12       Impact factor: 9.910

8.  Quantitation of IgG, IgA and IgM in the CSF by radioimmunoassay.

Authors:  E S Mingioli; W Strober; W W Tourtellotte; J N Whitaker; D E McFarlin
Journal:  Neurology       Date:  1978-10       Impact factor: 9.910

9.  Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age.

Authors:  S Rogers; R C Sanders; M P Alpers
Journal:  J Trop Med Hyg       Date:  1991-04

10.  Epidemiology of subacute sclerosing panencephalitis.

Authors:  J F Modlin; N A Halsey; D L Eddins; J L Conrad; J T Jabbour; L Chien; H Robinson
Journal:  J Pediatr       Date:  1979-02       Impact factor: 4.406

View more
  1 in total

1.  Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.

Authors:  Laurens Manning; Moses Laman; Henry Edoni; Ivo Mueller; Harin A Karunajeewa; David Smith; Ilomo Hwaiwhanje; Peter M Siba; Timothy M E Davis
Journal:  PLoS Negl Trop Dis       Date:  2011-01-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.